Aptose Biosciences
APTO
#10465
Rank
โ‚น0.39 B
Marketcap
โ‚น153.66
Share price
0.00%
Change (1 day)
805.50%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -โ‚น1.77 Billion

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.27 Billion, an increase over its 2023 earnings that were of -โ‚น4.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น1.77 Billion-22.27%
2024 -โ‚น2.27 Billion-51.82%
2023 -โ‚น4.71 Billion22.9%
2022 -โ‚น3.83 Billion-34.91%
2021 -โ‚น5.89 Billion17.36%
2020 -โ‚น5.02 Billion107.65%
2019 -โ‚น2.42 Billion-7.73%
2018 -โ‚น2.62 Billion160.68%
2017 -โ‚น1.01 Billion-20.27%
2016 -โ‚น1.26 Billion28.71%
2015 -โ‚น0.98 Billion
2013 -โ‚น0.56 Billion
2010 -โ‚น0.48 Billion-8.31%
2009 -โ‚น0.52 Billion
2006 -โ‚น0.96 Billion-156.93%
2005 โ‚น1.67 B-185.16%
2004 -โ‚น1.97 Billion458.58%
2003 -โ‚น0.36 Billion-63.66%
2002 -โ‚น0.97 Billion-8.04%
2001 -โ‚น1.06 Billion16.73%
2000 -โ‚น0.91 Billion294.99%
1999 -โ‚น0.23 Billion-6.51%
1998 -โ‚น0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-โ‚น3.06 Billion 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-โ‚น5.18 Billion 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-โ‚น5.65 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA